Studies show increased rate of all types of dementia in patients with AF, with new data finding treatment of AF lowers risk for cognitive dysfunction.
Nearly half of adults aged 50 to 64 years believe they are at least somewhat likely to develop dementia.
The study examined 3 psychotic phenotypes: psychosis wide, psychosis narrow, and delusions narrow.
More than half of individuals with Down syndrome aged 55 years or older have dementia claims and 32.7 percent have Alzheimer disease (AD) claims.
Intensive lowering of ambulatory blood pressure in older patients with hypertension reduced accumulation of small vessel disease in the white matter of the brain.
Researchers examined the selective vulnerability of the cholinergic system in Alzheimer disease (AD) by exploring the severity of accumulation and neuronal loss in the nucleus basalis of Meynert among AD subtypes.
Higher serum levels of elaidic acid, an objective biomarker for industrial trans fat, are associated with an increased risk for developing all-cause dementia and Alzheimer disease.
Low and high hemoglobin levels were associated with increased risk for dementia, white matter hyperintensity volume, and structural connectivity.
Alzheimer disease patients who initiate treatment with antipsychotic medications spend more days hospitalized than those who do not initiate antipsychotics.
In older adults, BMI-adjusted waist circumference was positively associated with the incidence of dementia.